Skip to main content
FinSpry Logo
FinSpry
KNSA logo
KNSA
(NASDAQ)
Kiniksa Pharmaceuticals International, plc
$80.20-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Kiniksa Pharmaceuticals International (KNSA) Stock Price & Financial Analysis

Kiniksa Pharmaceuticals International Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$78.01 - $79.93
52-Week High$82.94
52-Week Low$32.89
Open$78.28
Volume269.98K
Average Volume (3M)627.36K
Market Cap6.62B
Shares Outstanding83.40M
P/E Ratio (TTM)81.87
Forward P/E39.61
Price to Sales (P/S)7.85
Price to Book (P/B)10.09
EV/EBITDA59.19
Revenue (TTM)840.85M
Net Income (TTM)80.66M
Free Cash Flow (TTM)182.84M
EPS (TTM)$1.00
Profit Margin9.59%
Operating Margin11.92%
Return on Equity (ROE)12.33%
Debt to Equity0.01
50-Day MA$64.58
200-Day MA$50.06
52-Week Change137.21%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Kiniksa Pharmaceuticals International

What is the current stock price for KNSA?

As of the latest trading session, KNSA stock trades at $79.03. The 52-week range is $32.89–$82.94, with a day range of $78.01–$79.93.

What is the P/E ratio for KNSA?

Kiniksa Pharmaceuticals International's trailing P/E ratio is 81.9, meaning investors pay $81.9 for every $1 of annual earnings. The forward P/E is 39.6, reflecting analyst expectations for future earnings. Kiniksa Pharmaceuticals International operates in the Healthcare sector.

Does KNSA pay dividends?

Kiniksa Pharmaceuticals International does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for KNSA?

Based on 4 analysts, the consensus for KNSA is Buy.

What is the market cap of KNSA?

Kiniksa Pharmaceuticals International's market capitalization is $6.59B, classifying it as a mid-cap company. Kiniksa Pharmaceuticals International operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.